ArticleEMBO molecular medicine2022
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer.
Qian Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papercites it